• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:

    公开号:SU1366059A3
    申请号:SU853955801
    申请日:1985-09-20
    公开日:1988-01-07
    发明作者:Khirosi Koga；Takasi Mori；Takasi Dan；Mititaka Akima
    申请人:Chugai Pharmaceutical Co Ltd；
    IPC主号:
    专利说明:

    The invention relates to heterocyclic compounds, in particular the production of xanthone derivatives of the formula I
    where X, Υ, Ζ are the same or different - each is a hydrogen or halogen atom, or alkyl C 1 ~ C 4 , V is a hydrogen or halogen atom, provided that V is not a hydrogen atom in the 7th position when X, and Ζ - each hydrogen atom that can be used as diuretic agents. The goal is to obtain new compounds with valuable properties. The preparation of compounds I is carried out from a compound of formula II, where instead of OSB 2 is COOH OH group, and V, X, Υ and are indicated above, and compounds of the formula Br - CH 2 - CO 0K, where K is C 4 -C 4 alkyl medium Ν, Η-dimethylformamide. The process is carried out at 55 - 75 ° C, followed by alkaline hydrolysis of the obtained lower alkylcarbonyl derivative of compound I * Compound I does not show signs of toxicity in the tested doses. 1 tab.
    "511" 1366059 AZ
    1 1366059
    The invention relates to a method for producing new xanthone derivatives, which can be used as diuretics with the action of uricosuria, and can be used to treat edema or hypertension.
    The purpose of the invention is to obtain new biologically active compounds - derivatives of xanthones, with valuable properties.
    Example 1. A mixture of 2.6 g 4 — chlorine ~ 8 ~ fluorine ~ 3 — hydroxy-9 ~ hydroxy-9H-xan ~ tena, 2.8 g of potassium carbonate, 3.3 g 15 ethyl bromoacetate and 40 ml, Ν- dimethylformamide (DMF) is stirred at 6070 ° C for 4 hours. After the mixture is cooled, water is added to it, the resulting crystals are removed by filtering a 20-way radio, washed with water and dried. After recrystallization from ethanol, 3.4 g of ethyl 4-chloro-8-fluoro-9 ~ oxo-9H ~ xanthen-3 ~ yloxyacetate are obtained.
    A mixture of 3.3 g of this ester, 25
    1.9 g of sodium hydroxide and 100 ml of water are heated under reflux for 30 minutes. After cooling, the mixture is acidified with concentrated hydrochloric acid, the resulting 30 crystals are removed by filtration and dried. After recrystallization from DMF, 2.5 g of 4-chloro-8 ~ ιφτορ — 9 — oxo — 9H — xanthen — 3 — iloxy-acetic acid are obtained. Mp. 300 ° C. 35 Soedi- equation has the mass spectrum comprising a molecular ion peak at m / e 322.
    PRI me R. 2. A mixture of 1.2 g 4—
    —Chloro — 3 — hydroxy — 9 ~ oxo-9H-xanten,
    1.7 g of potassium carbonate, 2.1 g of ethyl- 40 bromoacetate and 30 ml of DMF are stirred at 60–70 ° C for 3 hours. After cooling the mixture, water is added, the resulting crystals are removed by filtration, washed with water and 45 are sewn . After recrystallization from ethanol, 1.1 g of 4-chloro ~ 9-oxo-9H ~ xanthene ~ 3 — yloxyacetate are obtained. T. pl.
    183 - 185 ° C.
    A mixture of 0.9 g of this βθ ester is 0.7 g of sodium hydroxide and 40 ml of water is heated under reflux for 1 hour. After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are recovered by filtration, washed with water and dried. After recrystallization from ethanol, 0.7 g of 4-chloro-9 is obtained.
    —Oxo-9H ~ xanthen-3 — iloxyacetic
    acid. T. pl. 280 - 281 ° C. The compound has a mass spectrum including a molecular ion peak at w / e 304.
    Example 3. A mixture of 1.0 g of 3-hydroxy ~ 4-methyl ~ 9 ~ oxo ~ 9H-xanthene, 1.5 g of potassium carbonate, 1.8 g of ethyl bromoacetate and 20 ml of DMF is stirred at 60–70 ° C for 2 h After cooling the mixture, 2 g of sodium hydroxide and 40 ml of water are added, the mixture is stirred at 90-100 ° C for 30 minutes. After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization of ethanol, 1.0 g of 4 ~ methyl ~ 9 ~ oxo ~ is obtained.
    —9H — Xanthen — iloxyacetic. acid.
    T. pl. 244 - 247 C. The compound has a mass spectrum including a molecular ion peak at w / e 284.
    Example 4. A mixture of 1.8 g of 8-fluoro-3-hydroxy-9 ~ oxo ~ 9H-xanten,
    3.2 g of potassium carbonate, 3.7 g of ethyl bromide acetate and 100 ml of DMF are stirred at 60 - 70 ° C for 4 hours. After cooling the mixture, 5 g of sodium hydroxide and 100 ml of water are added and the mixture is stirred at 90 -
    100 ° C for 30 minutes After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from ethanol, 2.0 g of 8-fluoro-9 ~ are obtained.
    —Oxo — 9H — Xanthen — 3 — Iloxyacetic acid. T. pl. 180 - 183 ° C. The compound has a mass spectrum including a molecular ion peak at w / e 288.
    Example 5. A mixture of 1.5 g of 8 — fluoro — 3 — hydroxy — 4 — methyl — 9-OXO — 9H — xanthene, 3.0 g of potassium carbonate, 3.6 g of ethyl bromoacetate and 40 ml of DMF are stirred at 60–70 ° C for 2 hours. After cooling the mixture, 3 g of sodium hydroxide and 40 ml of water are added and the mixture is stirred at 90-100 ° C for 30 minutes. After cooling, the mixture is acidified with hydrochloric acid. lot, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 1.4 g of 8 — fluorine — 4 — methyl — —9-ca co-9H-xanthen-3-yloxyacetic acid are obtained. T. pl. 259 - 261 ° С. The compound has a mass spectrum including a molecular ion peak at w / e 302.
    3 1366059
    four
    Example 6. A mixture of 1.3 g 2 '~ chl or-8 ~ f t ορ-3-οκ si-9-ok with o- 9 N ~ k with ant-e, 1.7 g potassium carbonate, 2, 1 g of ethyl bromoacetate and 30 ml of DMF (Peremet) ™ 5 are watered at 60 - 65 ° C for 3 hours.
    After cooling the mixture, 2 g of sodium hydroxide and 100 ml of water are added and the mixture is stirred at 90-100 ° C for 30 minutes. Yu
    After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 1.0 g is obtained 15
    2-chloro-8-fluoro-9-oxo-9H-xanthen-3 ~ -yloxyacetic acid. T. pl. 239242 ° C. The compound has a mass spectrum including a molecular ion peak at m / e 322. 20
    Example 7. A mixture of 2.6 g of 3 — chloro — 8 — fluorine — 2-hydroxy — 9 — oxo — 9H — xanthen, 3.4 g of potassium carbonate, 4.2 g of ethyl bromoacetate and 60 ml of DMF is stirred at 60–65 ° C for 5h. 25
    After cooling the mixture, 4 g of sodium hydroxide and 100 ml of water are added and the mixture is stirred at 90-100 ° C for 30 minutes. After cooling, the mixture is acidified with hydrochloric acid, the solid crystalline product is removed by filtration, washed with water and dried. After recrystallization from ethanol, 1.2 g of 3-chloro-8-fluoro-9-oxo-9H-d 5- xanthene-2-yloxyacetic acid are obtained.
    T. pl. 242 - 245 ° С. The compound has a mass spectrum including a molecular ion peak at t / e 322.
    Example 8. A mixture of 2 ^ 8 g to
    4,8-dichloro ~ 3-hydroxy ~ 9-oxo ~ 9H-xanthene
    3.4 g of potassium carbonate, 4.2 g of ethyl bromoacetate and 60 ml of DMF are stirred at 60 - 65 ° C for 6.5 hours. After cooling the mixture, 4 g of sodium hydroxide and 100 ml of sodium hydroxide are added, 100 ml of water, the solid crystals are separated by filtration, washed with water and dried. After recrystallization from DMF, 2.4 g of 4,8-dichloro-9-about-50 are obtained.
    co-9H-xanthene ~ 3-yloxyacetic acid. T. pl. 270 - 271 ° C. The compound has a mass spectrum including a molecular ion peak at m / e 338.
    Example 9. A mixture of 2.0 g of 4,6-dichloro-3-hydroxy-9-oxo-9H-xanten,
    3.4 g of potassium carbonate, 4.2 g of ethyl bromoacetate and 60 ml of DMF are stirred at 60 - 65 ° C for 4 hours. After
    cooling the mixture, 4 g of sodium hydroxide and 100 ml of water are added and the mixture is stirred at 90-100 ° C for 30 minutes. After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 1.5 g of 4, b-dichloro-9-oxo-9H-xanthen-3 ~ yloxyacetic acid are obtained. T. pl. 270 ° C. The compound has a mass spectrum including a molecular ion peak at m / e 338.
    Example 10. A mixture of 1.5 g of 4 — bromine — 8 — fluorine — 2 — hydroxy — 9 — oxo — 9H — Xanthen, 3.4 g of potassium carbonate, 4.2 g of ethyl bromoacetate and 60 ml of DMF are stirred at 60–65 ° C for 4 hours. After cooling the mixture, 2 g of sodium hydroxide and 100 ml of water are added and the mixture is stirred at 90-100 ° C for 30 minutes. After cooling, the mixture is acidified with hydrochloric acid and the solid crystals are removed by filtration, washed with water and dried. After recrystallization from ethanol, 1.2 g of 4 ~ br ~ ~ 8 ~ fluorine ~ 9 ~ ox-o-9H ~ xanthen-2-yloxyacetic acid are obtained. T. pl. 220-223 ° C. The compound has a mass spectrum including a molecular ion peak at m / e 366.
    Example 11. A mixture of 2.0 g
    4.7 — dichloro — 3 — oxy — 9 — oxo — 9H-xanthene,
    3.4 g of potassium carbonate, 4.2 g of ethyl bromoacetate and 60 ml of DMF are stirred at 60 - 65 ° C for 4 hours. After cooling the mixture, 4 g of sodium hydroxide and 100 ml of water are added, the mixture is stirred at 90 - 100 ° C for 30 min. After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 1.3 g of 4.7 ~ dichloro-9 ~ -oxo-9H-xanthen-3-yloxyacetic acid are obtained. T. pl. 262 - 263 ° C. The compound has a mass spectrum including an ionic molecular peak at m / e 338.
    Example 12. A mixture of 2.0 g of 4.5 — dichloro-3-hydroxy ~ 9-oxo ~ 9H-xanten,
    3.4 g of potassium carbonate, 4.2 g of ethyl bromoacetate and 60 ml of DMF are stirred at 60 - 65 ° C for 4 hours. After cooling the mixture, 4 g of sodium hydroxide and 100 ml of water are added and the mixture is stirred at 90 5 1366059
    6
    100 ° C for 30 minutes After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 1.5 g of 4.5 ~ dichloro ~ 9 ~ oxo ~ 9H — xanthene ~ 3 ~ yloxy -sucanoic acid are obtained. T. pl. 283 - 286 ° C. The compound has a mass spectrum including a molecular ion peak at w / e 338.
    Example 13. To a mixture of 14.2 g of 4 — chloro-orthinol-dimetyl ether a, 13.0 g of 2 ~ fluorobenzoyl chloride and 200 ml of 1,2-dichloroethane are added 11 g of aluminum chloride in small portions while cooling with ice and stirring.
    After refluxing for 1 h, the mixture is poured into ice-water and extracted with ether. After washing with water and drying, the solvent is distilled off. 32 g of 28% sodium methoxide (in methanol) and 300 ml of ethanol are added to the precipitate, the mixture is refluxed for 1 hour. After cooling the mixture, 200 ml of water are added, the crystals formed are removed by filtration, washed with water and dried. The resulting crystals are added to the pi — rindiohydrochloride heated to 185–195 ° C and the mixture is stirred at this temperature for 2 h.
    After cooling, water is added to the mixture, the formed crystals are separated by filtration, washed with water and dried. The resulting crystals are added to a mixture of 22.6 g of potassium carbonate, 27.4 g of ethyl bromoacetate and 400 ml of DMF and the resulting mixture is stirred at 65 - 75 ° C for 2 hours,
    After cooling the mixture, 40 g of sodium hydroxide and 400 ml of water are added and the mixture is stirred at 90 - 10 ° C for 1 hour. After cooling, the mixture is acidified with hydrochloric acid, the resulting crystals are isolated by filtration ,. washed with water and dried.
    By recrystallization from DMF, 19 g of 2 — chloro — 9 ~ oxo ~ 9H ~ xanthenes ~ ~ 3 ~ yloxyacetic acid are obtained. T. pl.
    248 - 249 ° С. The compound has a mass spectrum including a molecular ion peak at w / e 304.
    Example 14. A mixture of 1.5 g
    3 — chloro-2 ~ hydroxy ~ 9-oxo-9H-to santen,
    2.5 g of potassium carbonate, 3.1 g of ethyl bromoacetate and 40 ml of DMF are stirred at 65 - 75 ° C for 2 hours. After cooling the mixture, 4 g of sodium hydroxide and 100 ml of water are introduced into it and the resulting mixture is stirred at 90 - 100 ° C for 30 minutes After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from ethanol, 1.5 g of 3-chloro-9-oxo-9H-xanthene-2 ~ yloxyacetic acid are obtained. T. pl. 237 - 238 ° С. The compound has a mass spectrum including a molecular ion peak at w / e 304.
    Example 15. A mixture of 2.0 g
    4 — bromo — 2 — oxy — 9 — oxo — 9H — xanten,
    1.9 g of potassium carbonate, 2.3 g of ethyl 20 bromoacetate and 20 ml of DMF are stirred at 60–70 ° C for 1.5 hours. After cooling the mixture, sodium hydroxide (4 g) and 40 ml of water are introduced into it and the resulting mixture stirred at
    25 90 - 100 ° C for 30 minutes After cooling, the mixture is acidified with hydrochloric acid, the resulting solid crystals are recovered by filtration, washed with water and dried. After
    30 g of recrystallization from ethanol gives 1.8 g of 4 ~ bromo-9 ~ oxo ~ 9H ~ xanthene-2-yloxyacetic acid. T. pl. 219 - 221 ° C. The compound has a mass spectrum including a molecular ion 35 ny peak at w / e 348.
    Example 16, Mix 1.0 g
    1 — chloro-3 ~ hydroxy-3-oxo-9H-xanten,
    1.1 g of potassium carbonate, 1.4 g of ethyl bromoacetate and 20 ml of DMF are stirred
    40 at 60 - 70 ° C for 5 hours. After cooling the mixture, 2 g of sodium hydroxide and 50 ml of water are introduced into it and the resulting mixture is stirred at 90 - 100 ° C for 30 minutes. After
    45 cooling the mixture is acidified with hydrochloric acid and the solid crystals are removed by filtration, washed with water and dried. After recrystallization from ethanol, 0.8 g is obtained.
    50 1-chloro ~ 9 ~ oxo-9H-xanthene ~ 3-yloxy-acetic acid. T. pl. 231 - 233 ° C. The compound has a mass spectrum including a molecular ion peak at w / e 304.
    Example 17. A mixture of 2.0 g
    1,2-dichloro ~ 3 ~ hydroxy “9 ~ oxo-9H ~ xanten
    2.0 g potassium carbonate, 2.4 g ethyl ~
    bromoacetate and 40 ml of DMF mix
    at 60 - 70 ° C for 1.5 hours. After
    7 1366059
    eight
    cooling the mixture, it is injected with 2 g of sodium methoxide and 100 ml of water, and the resulting mixture is stirred at 90-100 ° C for 30 minutes. After cooling the mixture, it is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 1.7 g of 1,2-dichloro-9 — oxo — 9H — xanthene – 3 — iloxyacetic acid are obtained. T. pl. 288 - 290 ° C. The compound has a mass spectrum including a molecular ion peak at. t / e 338.
    Example 18. A mixture of 1.1 g
    2-hydroxy ~ 3-methyl ~ 9-oxo-9H-xanten,
    1.4 g of potassium carbonate, 1.7 g of ethyl bromoacetate and 20 ml of DMF are stirred at 60 - 70 ° C for 3 hours. After cooling the mixture, 4 g of sodium hydroxide and 100 ml of water are introduced into it, the mixture is stirred at 90 - 100 ° C for 1 hour. After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 1.3 g of 3-methyl-9-oxo-9H-xanthen-2 ~ yloxyacetic acid are obtained. T. pl. 225 - 227 ° C. The compound has a mass spectrum including a molecular ion peak at m / e 284.
    Example 19. A mixture of 5.0 g 3—
    —Oxy — 1 — methyl-9 — oxo — 9H — Xanthen,
    6.0 g of potassium carbonate, 7.0 g of ethyl bromoacetate and 100 ml of DMF are stirred at 60 - 70 ° C for 5 hours. After cooling the mixture, 10 g of sodium oxide and 200 mp of water are introduced into it and the resulting mixture is stirred at 90 - 100 ° C for 1 hour. After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from ethanol, 5.0 g of 1-methyl-9 ~ oxo ~ 9H-xanthen-3 ~ yloxyacetic acid are obtained. T, pl. 189 - 190 ° C. The compound has a mass spectrum including a molecular ion peak at w / e 284.
    Example 20. A mixture of 1.3 g of 2-chloro-3-hydroxy-1-methyl-9 ~ oxo-9H-xan-ten, 1.4 g of potassium carbonate, 1.7 g of ethyl bromoacetate and 20 ml of DMF is stirred at 60 - 70 ° C for 5 hours. After cooling the mixture, 4 g of sodium hydroxide and 100 ml of water are introduced into it and the mixture is stirred
    at 90-100 ° C for 1 hour. After. cooling the mixture is acidified with hydrochloric acid, the solid crystals are removed by filtration, washed with water and dried. After recrystallization from DMF, 0.9 g of 2-chloro-1 — methyl — 9 — oxo — 9H — Xanthen — 3 — iloxy-acetic acid is obtained. T. pl. 275 - 278 ° С.
    10 The compound has a mass spectrum including a molecular ion peak at m / e 318.
    Example 21. A mixture of 5.0 g of 2-bromo-3-hydroxy-9-oxo-9H-xanthene,
    15 7.1 g of potassium carbonate, 8.6 g of ethyl bromoacetate and 80 ml of DMF are stirred at 55 - 65 ° C for 5 hours. After cooling the mixture, 10 g of sodium hydroxide and 250 ml of water are introduced into it.
    2θ and the resulting mixture is stirred at 90-100 ° C for 2 hours. After cooling, the mixture is acidified with hydrochloric acid, the solid crystals are recovered · by filtration, washed
    25 with water and dry. After recrystallization from ethanol, 3.0 g are obtained.
    2-6rom-9 — oxo-9H-xanthen-3 — yloxyacetic acid. T. pl. 227 - 230 ° C. The compound has a mass spectrum, including
    A molecular ion peak at w / e 348.
    Example 22. A mixture of 7.5 g of 2,4-dichloro ~ 3 ~ hydroxy-9-oxo-9H ~ xanthe-. on, 7.5 g of potassium carbonate, 9.0 g of ethyl bromoacetate and 100 ml of DMF are stirred at. 55 -. 65 ° C for 3 hours After cooling the mixture, it is introduced 20 g of sodium hydroxide and 250 ml of water, the resulting mixture was pe40 remeshivayut at 90 -. 100 C for 1 hour After cooling the mixture, it was acidified with hydrochloric acid, the solid the crystals are removed by filtration, washed with water and dried. After
    4 5 recrystallization from ethanol gives 4.0 g of 2,4-dichloro-9 — oxo-9H-xanthen-3-yloxyacetic acid. T. pl. 225 - 228 ° C. The compound has a mass spectrum including molecular ion—
    5 θ ny peak at m / e 338,
    Example 23. A mixture of 1.8 g
    3- hydroxy ~ 2-methyl — 9-oxo-9H ~ xanten,
    2.2 g of potassium carbonate, 2.7 g of ethyl bromoacetate and 40 ml of DMF are mixed
    oo at 60 - 70 ° C for 2 hours. After
    cooling the mixture injected 3.2 g
    sodium hydroxide and 40 ml of water,
    the mixture is stirred at
    90 - 100 ° C for 1 h. After Ox9
    1366059
    ten
    the mixture is acidified with hydrochloric acid, solid crystals are removed by filtration, washed with water; and dried. After recrystallization from ethanol, 1.8 g of 2-methyl-9 ~ oxo ~ 9H ~ xanthene ~ 3-yloxyacetic acid are obtained. T. pl. 236 - 238 ° С. The compound has a mass spectrum including a molecular ion peak at w / e 284.
    Example 24. A mixture of 8.0 g of 2-chloro-3-hydroxy ~ 9 ~ oxo ~ 9H ~ xanten,
    13 g of potassium carbonate, 2 ~ bromethanol and 200 ml of DMF are stirred at 45 ~
    55 ° C for 3 hours. After the solvent is distilled off in vacuum, water is added to the residue and the solid crystals are removed by filtration, washed, water and dried. After recrystallization from a mixed solvent of DMF and water, 6.0 g of 2-chloro ~ 3- (2-hydroxyethoxy) -9 ~ oxo-9H ~ xanten are obtained. T. pl. 153 156 ° C. The compound has a mass spectrum including a molecular ion peak at w / e 290.
    Known diuretics have the effect of uricosuria, similar to the compounds of the invention, and are phenoxyacetic acids, a typical example of which is thienyl acid.
    Conventional diuretic hypertonic drugs are widely used as the main drugs for the treatment of hypertension, but they can cause hyperuricemia or a side effect. In addition, hypertension is often complicated by hyperuricemia and many cases of hyperuricemia are caused by impaired uric acid excretion, therefore, the development of diuretics with uricosuria is necessary. Thienyl acid is a potential diuretic agent with uricosuria activity, but it can cause liver dysfunction as a side effect.
    As a result of research, it has been established that xanthone derivatives of formula (I) possess both the action of uricosuria and diuretic effects. and at the same time cause minimal side effects that have an effect on the liver.
    The diuretic and uricosuric actions of the compounds of the formula I are confirmed by the experiment carried out according to the following procedure.
    Wistar-Imamishi rats of six weeks of age, which were not given food for 24 hours, were divided into groups of 4 or 5 pcs. in each group, so that the animals of each corpse ·
    10 py excreted almost the same amount of urine. After urination caused by artificial urination, rats were orally administered to the rats, which are suslic ·
    15 were filled with physiological saline containing 3% gum arabic. The volume dose of the compound administered was 25 ml per kg of body weight. The suspension was usually administered
    20 in the amount of 100 mg / kg. Oral physiological saline solution containing 3% gum arabic was administered orally to the control rats. The animals were confined to separate metabolic cells and the urine excreted by each animal was collected for 6 hours after administration of the test compounds or physiological saline after starvation.
    The urine volume was determined directly using a measuring cylinder after artificial urination into this cylinder, and the amount of urine per kilogram of animal weight was calculated. Using the method of uricase catalase, the amount of uric acid excreted in the urine was determined.
    The results are presented in the table, from which it can be seen that the compounds of formula (I) exhibit a significant degree of uricosuric and diuretic activity, which is maintained for a long period and depends on the dose.
    45 The compounds of the invention showed no toxicity in the tested doses.
    权利要求:
    Claims (1)
    [1]
    Claim
    fifty
    The method of obtaining xanthonic pro—
    where X, Yi Ζ are identical or different
    ny, each is hydrogen,
    and
    1366059 12
    or halogen, or C., C 4 -alkyl;
    V is hydrogen or halogen, provided that V is not hydrogen in the 7th position, when X, Y and Ζ are each hydrogen,
    different unity of the formula
    HE,
    I so-10
    (Ii)
    where V, Χ, .ϊ and Ζ have the indicated meanings,
    react with a compound of formula III
    Bg - CH g - COOE (III)
    where E is C ^ -C ^ -alkyl;
    in Κ, Ν-dimethylformamide medium at 5575 ° C followed by alkaline hydrolysis of the resulting lower alkylcarbonyl derivative of the compound of formula (I).
    Connection example Urine count Uric acid ml / kg % mg / kg % The control 17.7 + 3.9 100 3.44 + 0.57 100 _ and 18.1 + 0.5 100 3.53 + 0.08 100 "II" 16.7 + 6.9 100 3.05 + 0.48 100 eleven _ 14.7 + 3.3 100 2.38 + 0.23 100 Compound 1 26.6 + 2.1 146.6 5.40 + 0.39 153.3 e 2 29.8 + 5.2 164.4 e4.91 + 0.38 141.1 e 3 23.1 + 3.3 127.2 e * 4 21.9 + 3.1 120.5 5 20.6 + 2.4 113.3 6 23.0 + 2.5 126.7 th4.28 + 0.38 121.5 th 7 19.8 + 1.7 109.0 4.81 + 0.77 136.4 b 8 25.9 + 2.0 142.6 e5.07 + 0.55 143.7 e 9 23.5 + 1.8 129.3 th3.88 + 0.54 110.0 10 30.1 + 4.3 165.7 e4.42 + 0.48 125.5 b AND 35.0 + 4.3 193.2 e3.90 + 0.19 1 10.5 12 30.4 + 2.6 167.8 e2.72 + 0.34 77.2 th thirteen 35.4 + 7.6 199.5 e5.11 + 1.00 148.6 e 14 35.8 +3.9 197.5 e3.49 + 0.22 99.0 fifteen 29.9 + 3.6 165.0 e3.36 + 0.18 95.3 16 47.5 + 4.4 262.0 e3.72 + 0.56 105,4
    thirteen
    1366059
    14
    Table continuation
    Compound Urine count Uric acid hhrhameru ml / kg % mg / kg 7 17 32.5 + 2.1 178.9 C4.46 + 0.31 126.5 6 18 23.4 + 2.5 128.9 th3.84 + 0.18 109.0 19 38.5 + 4.8 212.4 C4.85 + 0.33 137.4 e 20 28.1 + 2.7 154.9 e. 2.96 + 0.23 84.0 21 31.8 +6.6 190.8 e3.86 + 0.61 126.3 b 22 30.0 + 1.5 165.2 e3.56 + 0.17 100.9 23 36.9 + 3.3 250.3 e3.13 + 0.22 131.7 ° 1 ——— g— —————————— ——- P r and m e I a n and e. A : p <0.05, c: p <0.01, s P <0.001.
    类似技术:
    公开号 | 公开日 | 专利标题
    US4725691A|1988-02-16|2-[8-quinolinyl]-sulphinyl-1H-benzimidazole
    US4440929A|1984-04-03|Imidazoquinoxaline compounds
    EP0175376B1|1991-04-03|Xanthone derivatives and process for producing the same
    DE2228012C3|1980-01-17|Phthalide ester of 6- [D | - a aminophenylacetamido] penicillanic acid and process for its preparation
    SU1366059A3|1988-01-07|Method of obtaining xanthene derivatives
    BG60337B2|1994-05-27|4-amino-2-|1,4-benzodioxan-2-carbonyl|quinazolines with antihypertension effect
    CS199690B2|1980-07-31|Process for preparing derivatives of spiro-hydantoine
    DE2500157A1|1976-07-22|BENZOIC ACIDS AND DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
    US4505921A|1985-03-19|Sulfonylurea compounds and their use in treating diabetes
    US4725676A|1988-02-16|5-|-2-hydroxybenzene-acetic acids and salts and lactones thereof having a potentially inhibitory effect on 15-hydroxy-prostaglandin dehydrogenase
    EP0068563A2|1983-01-05|Heterocyclic acetic acid compounds and compositions for treating bone diseases
    EP0096890B1|1987-11-25|Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives
    SU1083909A3|1984-03-30|Process for preparing 6-substituted derivatives of pyranone
    DE3014813A1|1980-11-13|2-HYDROXY-5- | BENZOESIC ACID DERIVATIVES
    US3272832A|1966-09-13|Nicotinic acid derivatives and process for the preparation thereof
    FR2553417A1|1985-04-19|CHLORO-4-FURO- | -PYRIDINE DERIVATIVES AND PROCESS FOR PREPARING THE SAME
    SU1493105A3|1989-07-07|Method of producing heterocyclic compounds
    KR860000768B1|1986-06-23|Substituted preparing substituted furofuranone derivatives
    KR960004536B1|1996-04-06|Process for preparing thiazolobenzimidazoles and intermediates used therein
    US4791209A|1988-12-13|Furobenzisoxazole derivatives
    US4112102A|1978-09-05|Halopyridyl derivatives of m-aminotetramisole as anthelmintics
    KR950008316B1|1995-07-27|1-hydroxy-oxo-5h-pyrido|-phenoxazine-3-carboxylic acid esters
    JPH06279453A|1994-10-04|Pyridothiazine acetic acid derivative, its production and use thereof
    DK157025B|1989-10-30|METHOD OF ANALOGUE FOR THE PREPARATION OF 4H-FURO | INDOLES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
    SU1498391A3|1989-07-30|Method of producing furobenzoxazol derivatives
    同族专利:
    公开号 | 公开日
    ES8801298A3|1987-12-16|
    CN85107319A|1987-04-08|
    KR860002492A|1986-04-26|
    ES557745A0|1987-12-16|
    JPS6176476A|1986-04-18|
    CN1010777B|1990-12-12|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    CN101372538B|2007-08-21|2012-08-29|北京万和芯源生物技术有限公司|Ultraviolet light assisted surface modification method and product with surface formed thereby|
    CN102675672B|2007-08-21|2014-06-18|北京万和芯源生物技术有限公司|Ultraviolet aided surface modification method and product with surface formed by method|
    CN102643447B|2007-08-21|2013-07-24|北京万和芯源生物技术有限公司|Ultraviolet light assisted surface modification method and product with surface formed by means of method|
    CN101270110B|2008-04-29|2011-05-04|中国人民解放军第二军医大学|Novel sulfonyl substituted benzophenone oxide compounds, prepraring method and application thereof|
    US8673920B2|2009-05-06|2014-03-18|Merck Sharp & Dohme Corp.|Inhibitors of the renal outer medullary potassium channel|
    CN102276564A|2011-06-23|2011-12-14|徐州师范大学|Synthetic method of 12-phenyl-benzo[b] xanthenetrione derivative|
    CN102617538A|2012-03-08|2012-08-01|南京大学|Xanthone type small molecule with effect of broad spectrum regulation on micro ribonucleic acid and synthesis method and application thereof|
    CN105294637B|2015-08-08|2018-02-09|沈阳药科大学|Nitrogenousketone derivatives and its preparation method and application|
    CN108047187B|2017-11-22|2021-12-10|河南科技大学|Preparation method of xanthone|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP59196796A|JPS6176476A|1984-09-21|1984-09-21|Xanthone derivative|
    [返回顶部]